4DMedical Ltd
ASX:4DX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.41
0.79
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
4DMedical Ltd
4DMedical Ltd
Total Current Assets
4DMedical Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
4DMedical Ltd
ASX:4DX
|
Total Current Assets
AU$39.1m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
|
Mach7 Technologies Ltd
ASX:M7T
|
Total Current Assets
AU$33.9m
|
CAGR 3-Years
12%
|
CAGR 5-Years
42%
|
CAGR 10-Years
50%
|
|
|
CogState Ltd
ASX:CGS
|
Total Current Assets
$43.5m
|
CAGR 3-Years
8%
|
CAGR 5-Years
36%
|
CAGR 10-Years
16%
|
|
|
Pro Medicus Ltd
ASX:PME
|
Total Current Assets
AU$206.6m
|
CAGR 3-Years
33%
|
CAGR 5-Years
32%
|
CAGR 10-Years
27%
|
|
|
Medibio Ltd
ASX:MEB
|
Total Current Assets
AU$304.5k
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
N/A
|
|
|
Medadvisor Ltd
ASX:MDR
|
Total Current Assets
AU$32.5m
|
CAGR 3-Years
15%
|
CAGR 5-Years
140%
|
CAGR 10-Years
56%
|
|
4DMedical Ltd
Glance View
4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-08-07. The firm is focused on development of a non-invasive respiratory imaging solution using four-dimensional imaging. The firm's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The company enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.
See Also
What is 4DMedical Ltd's Total Current Assets?
Total Current Assets
39.1m
AUD
Based on the financial report for Jun 30, 2024, 4DMedical Ltd's Total Current Assets amounts to 39.1m AUD.
What is 4DMedical Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
48%
Over the last year, the Total Current Assets growth was -50%. The average annual Total Current Assets growth rates for 4DMedical Ltd have been -23% over the past three years , 48% over the past five years .
You don't have any saved screeners yet
